Open AccessCD19 Chimeric Antigen Receptor Natural Killer Cells Can Safely Induce Remission in Lymphoid Malignancies
Author(s) -
Frederick L. Locke
Publication year - 2020
Publication title -
the hematologist
Language(s) - English
Resource type - Journals
ISSN - 1551-8779
DOI - 10.1182/hem.v17.3.10367
Subject(s) - chimeric antigen receptor , cd19 , antigen , immunology , receptor , cancer research , medicine , biology , immunotherapy , immune system